Nektar Therapeutics (NQ: NKTR )

15.71 USD -0.50 (-3.08%)

Streaming Delayed Price Updated: 5:43 AM EDT, Oct 30, 2020 Add to My Watchlist

Price and Volume

Volume	6,690
Open	16.21
Bid (Size)	15.13 (16)
Ask (Size)	19.00 (1)
Prev. Close	16.21
Today's Range	15.71 - 16.21
52wk Range	13.63 - 28.60
Shares Outstanding	171,402,476
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors for 2020 American College of Rheumatology (ACR) Congress

October 29, 2020

Nektar Therapeutics (NASDAQ: NKTR) announced today that it will webcast an analyst and investor conference call at ACR 2020 with company management and Dr. Klatzmann of Sorbonne University on...

Nektar to Announce Financial Results for the Third Quarter 2020 on Thursday, November 5, 2020, After Close of U.S.-Based Financial Markets

October 28, 2020

Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2020 on Thursday, November 5, 2020, after the close of U.S.-based financial markets. Howard Robin, President...

Performance

YTD	-25.05%	-25.05%
1 Month	-6.99%	-6.99%
3 Month	-32.49%	-32.49%
6 Month	-18.18%	-18.18%
1 Year	-10.48%	-10.48%

More News

Nektar Therapeutics Announces Phase 1b Clinical Study to Evaluate Bempegaldesleukin for Treatment of Patients Diagnosed with Mild COVID-19

October 27, 2020

Vaccibody AS and Nektar Therapeutics Announce First Patient Dosed in a Phase 1/2a Study Arm Evaluating VB10.NEO, a Personalized Neoantigen Cancer Vaccine, with Bempegaldesleukin (NKTR-214) in Patients

August 12, 2020

Nektar Therapeutics Reports Second Quarter 2020 Financial Results

August 06, 2020

Nektar to Announce Financial Results for the Second Quarter 2020 on Thursday, August 6, 2020, After Close of U.S.-Based Financial Markets

July 28, 2020

Data Presented from Phase 1b Study of NKTR-358, a Novel T Regulatory Cell Stimulator, at Annual European Congress of Rheumatology (EULAR 2020)

June 04, 2020

Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors During 2020 Virtual European Congress of Rheumatology (EULAR 2020)

May 29, 2020

Interesting NKTR Put And Call Options For December 18th

October 16, 2020

PBE's Holdings Imply 31% Gain Potential

October 05, 2020

October 23rd Options Now Available For Nektar Therapeutics (NKTR)

September 03, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.